Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Jupiter Neurosciences (JUNS) Equity Average (2024 - 2025)

Jupiter Neurosciences (JUNS) has disclosed Equity Average for 2 consecutive years, with -$887217.5 as the latest value for Q4 2025.

  • Quarterly Equity Average fell 12.38% to -$887217.5 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$887217.5 through Dec 2025, down 12.38% year-over-year, with the annual reading at $1.2 million for FY2025, N/A changed from the prior year.
  • Equity Average for Q4 2025 was -$887217.5 at Jupiter Neurosciences, down from $698767.5 in the prior quarter.
  • The five-year high for Equity Average was $3.6 million in Q1 2025, with the low at -$5.7 million in Q2 2024.